Pazoo, Inc. (OTC Pink: PZOO) is engaged as a health, wellness, and safety company, which owns a stake in MA & Associates, LLC, a cannabis testing lab based in Las Vegas, NV. Shares of the cannabis testing company shot up 1,000%, during trading on Thursday, February 22, 2018. Over the past month, Pazoo, Inc. has seen average daily volume of 42.07 million shares. However, volume of 778.34 million shares or dollar volume of $856,174, exchanged hands during trading on Thursday.
Shares of Pazoo, Inc. soared today, after MA & Associates, LLC provided an update on its cannabis testing laboratory in Las Vegas, NV. The company is completing the final touches on its new laboratory in time for the final inspection by State of Nevada officials. This is the final step before the lab can officially be licensed by the state and be open for business. The lab preparation team has worked extensively to ensure that all the strict regulations and quality control measures are in place. Here is the full press release detailing of the preparations for the final inspection:
Pazoo, Inc. Press Release:
EAST HANOVER, N.J., Feb. 22, 2018 /PRNewswire/ — Pazoo, Inc. (OTC: PZOO) is pleased to announce that MA & Associates LLC, (DBA: MA Analytics), a cannabis testing laboratory located in Las Vegas, Nevada partially owned by Pazoo, has made significant strides in completing operations and procedures ahead of the laboratory’s final inspection by the State of Nevada.
MA Analytics is finalizing the policies and procedures as well as the operations ahead of the above mentioned final inspection and its much anticipated opening for business to customers. The lab has completed some and is close to finishing the remaining standard operating procedures including methods and validations while ensuring everything is up to the rigorous testing and compliance policies set forth by the State of Nevada.
Additionally, in preparation for working with customers, the lab has hired a general manager with extensive experience in sales, marketing, and professional relationship building, and client acquisition. She has already started selling activities.
The State Inspection is the last step before the lab can open and start generating revenue. The testing performed by MA & Associates LLC, as required by Nevada, will protect consumers from contaminants, chemicals and other impurities within the cannabis plant, ensuring the consumer is getting the best possible product.
Pazoo’s acting CEO Steve Basloe said, “We are very pleased to announce that the lab is close to scheduling the State inspection, the last major step needed in order to finally be open and start generating revenue. We are excited to start the sales and marketing of the lab along with our general manger. We understand the frustration in delays in the lab opening but we are ensuring that as the State continues to tighten their testing limits and standards, we are not making the mistakes some other labs have made in the past. We look forward to getting the lab open and making this a profitable business moving forward.”
About Pazoo, Inc.
Pazoo, Inc. is focused on health, wellness and safety. Through our investment in MA & Associates LLC, in connection with the projected opening of the lab, Pazoo will provide industry leading laboratory testing of cannabis. Upon its opening, the lab will provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities.
Safe Harbor Statement
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.